Literature DB >> 30903160

TISIDB: an integrated repository portal for tumor-immune system interactions.

Beibei Ru1, Ching Ngar Wong1, Yin Tong1, Jia Yi Zhong1, Sophia Shek Wa Zhong1, Wai Chung Wu1, Ka Chi Chu1, Choi Yiu Wong1, Chit Ying Lau1, Ian Chen1, Nam Wai Chan1, Jiangwen Zhang1.   

Abstract

SUMMARY: The interaction between tumor and immune system plays a crucial role in both cancer development and treatment response. To facilitate comprehensive investigation of tumor-immune interactions, we have designed a user-friendly web portal TISIDB, which integrated multiple types of data resources in oncoimmunology. First, we manually curated 4176 records from 2530 publications, which reported 988 genes related to anti-tumor immunity. Second, genes associated with the resistance or sensitivity of tumor cells to T cell-mediated killing and immunotherapy were identified by analyzing high-throughput screening and genomic profiling data. Third, associations between any gene and immune features, such as lymphocytes, immunomodulators and chemokines, were pre-calculated for 30 TCGA cancer types. In TISIDB, biologists can cross-check a gene of interest about its role in tumor-immune interactions through literature mining and high-throughput data analysis, and generate testable hypotheses and high quality figures for publication.
AVAILABILITY AND IMPLEMENTATION: http://cis.hku.hk/TISIDB. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30903160     DOI: 10.1093/bioinformatics/btz210

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  474 in total

1.  m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.

Authors:  Tao Zhang; Ping Sheng; Yuting Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-03       Impact factor: 4.553

2.  Downregulation of SETBP1 promoted non-small cell lung cancer progression by inducing cellular EMT and disordered immune status.

Authors:  Hao-Ran Li; Jian Gao; Chun Jin; Jia-Hao Jiang; Jian-Yong Ding
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

3.  VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Authors:  Qin Huo; Zhenwei Li; Siqi Chen; Juan Wang; Jiaying Li; Ni Xie
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

4.  Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.

Authors:  Yanpeng Ding; Nuomin Liu; Mengge Chen; Yulian Xu; Sha Fang; Wenbin Xiang; Xinying Hua; Gaili Chen; Yahua Zhong; Haijun Yu
Journal:  World J Surg Oncol       Date:  2021-04-22       Impact factor: 2.754

5.  YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.

Authors:  Jian Hu; Dongxu Qiu; Anze Yu; Jiao Hu; Hao Deng; Huihuang Li; Zhenglin Yi; Jinbo Chen; Xiongbing Zu
Journal:  Front Oncol       Date:  2021-05-06       Impact factor: 6.244

6.  MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.

Authors:  Haoya Xu; Ruoyao Zou; Feifei Li; Jiyu Liu; Nannan Luan; Shengke Wang; Liancheng Zhu
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

7.  CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6.

Authors:  Peng Xu; XiaoLan Xu; Xiao Wu; LiXiang Zhang; Lei Meng; ZhangMing Chen; WenXiu Han; Jie Yao; AMan Xu
Journal:  Gastric Cancer       Date:  2021-07-22       Impact factor: 7.370

8.  ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.

Authors:  Xu Lin; Zhi-Yong Wang; Gang Xue; Xiao-Jing Qin; Jing-Fang Wu; Geng Zhang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

9.  Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer.

Authors:  Hai-Yu Shen; Fang-Ze Wei; Qian Liu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

10.  Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.

Authors:  Panpan Zhang; Tong Su; Shu Zhang
Journal:  J Immunol Res       Date:  2021-06-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.